|
1
|
Taran SJ, Taran R and Malipatil NB:
Pediatric osteosarcoma: An updated review. Indian J Med Paediatr
Oncol. 38:33–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Deng Z, Liu X, Jin J, Xu H, Gao Q, Wang Y
and Zhao J: Histone deacetylase inhibitor trichostatin a promotes
the apoptosis of osteosarcoma cells through p53 signaling pathway
activation. Int J Biol Sci. 12:1298–1308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moirangthem A, Bondhopadhyay B, Mukherjee
M, Bandyopadhyay A, Mukherjee N, Konar K, Bhattacharya S and Basu
A: Simultaneous knockdown of uPA and MMP9 can reduce breast cancer
progression by increasing cell-cell adhesion and modulating EMT
genes. Sci Rep. 6:219032016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu J, Song G, Tang Q, Zou C, Han F, Zhao
Z, Yong B, Yin J, Xu H, Xie X, et al: IRX1 hypomethylation promotes
osteosarcoma metastasis via induction of CXCL14/NF-κB signaling. J
Clin Invest. 125:1839–1856. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bielack SS, Kempf-Bielack B, Delling G,
Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M,
Winkelmann W, et al: Prognostic factors in high-grade osteosarcoma
of the extremities or trunk: An analysis of 1,702 patients treated
on neoadjuvant cooperative osteosarcoma study group protocols. J
Clin Oncol. 20:776–790. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang JY, Wu PK, Chen PC, Yen CC, Hung GY,
Chen CF, Hung SC, Tsai SF, Liu CL, Chen TH and Chen WM:
Manipulation therapy prior to diagnosis induced primary
osteosarcoma metastasis-from clinical to basic research. PLoS One.
9:e965712014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mercadante S: Malignant bone pain:
Pathophysiology and treatment. Pain. 69:1–18. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mercadante S and Fulfaro F: Management of
painful bone metastases. Curr Opin Oncol. 19:308–314. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Harris JD: Management of expected and
unexpected opioid-related side effects. Clin J Pain. 24 (Suppl
10):S8–S13. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Weber M and Huber C: Documentation of
severe pain, opioid doses, and opioid-related side effects in
outpatients with cancer: A retrospective study. J Pain Symptom
Manage. 17:49–54. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yi XJ, Zhao YH, Qiao LX, Jin CL, Tian J
and Li QS: Aberrant Wnt/β-catenin signaling and elevated expression
of stem cell proteins are associated with osteosarcoma side
population cells of high tumorigenicity. Mol Med Rep. 12:5042–5048.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Talmadge JE and Fidler IJ: AACR centennial
series: The biology of cancer metastasis: Historical perspective.
Cancer Res. 70:5649–5669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bacac M and Stamenkovic I: Metastatic
cancer cell. Annu Rev Pathol. 3:221–247. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Duffy MJ, McGowan PM and Gallagher WM:
Cancer invasion and metastasis: Changing views. J Pathol.
214:283–293. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fidler IJ: The pathogenesis of cancer
metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tarin D: Cell and tissue interactions in
carcinogenesis and metastasis and their clinical significance.
Semin Cancer Biol. 21:72–82. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yadav L, Puri N, Rastogi V, Satpute P,
Ahmad R and Kaur G: Matrix metalloproteinases and cancer-roles in
threat and therapy. Asian Pac J Cancer Prev. 15:1085–1091. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yilmaz M, Christofori G and Lehembre F:
Distinct mechanisms of tumor invasion and metastasis. Trends Mol
Med. 13:535–541. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kansara M and Thomas DM: Molecular
pathogenesis of osteosarcoma. DNA Cell Biol. 26:1–18. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jayaprakasha GK, Jaganmohan Rao L and
Sakariah KK: Antioxidant activities of curcumin, demethoxycurcumin
and bisdemethoxycurcumin. Food Chem. 98:720–724. 2006. View Article : Google Scholar
|
|
25
|
Shishodia S: Molecular mechanisms of
curcumin action: Gene expression. Biofactors. 39:37–55. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Masuda T, Hidaka K, Shinohara A, Maekawa
T, Takeda Y and Yamaguchi H: Chemical studies on antioxidant
mechanism of curcuminoid: Analysis of radical reaction products
from curcumin. J Agric Food Chem. 47:71–77. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li YB, Gao JL, Zhong ZF, Hoi PM, Lee SM
and Wang YT: Bisdemethoxycurcumin suppresses MCF-7 cells
proliferation by inducing ROS accumulation and modulating
senescence-related pathways. Pharmacol Rep. 65:700–709. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luo C, Du Z, Wei X, Chen G and Fu Z:
Bisdemethoxycurcumin attenuates gastric adenocarcinoma growth by
inducing mitochondrial dysfunction. Oncol Lett. 9:270–274. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hongtao C, Youling F, Fang H, Huihua P,
Jiying Z and Jun Z: Curcumin alleviates ischemia
reperfusion-induced late kidney fibrosis through the APPL1/Akt
signaling pathway. J Cell Physiol. 233:8588–8596. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liao CL, Chu YL, Lin HY, Chen CY, Hsu MJ,
Liu KC, Lai KC, Huang AC and Chung JG: Bisdemethoxycurcumin
suppresses migration and invasion of human cervical cancer HeLa
cells via inhibition of NF-ĸB, MMP-2 and −9 pathways. Anticancer
Res. 38:3989–3997. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu J, Yang H, Zhou X, Wang H, Gong L and
Tang C: Bisdemethoxycurcumin suppresses migration and invasion of
highly metastatic 95D lung cancer cells by regulating E-cadherin
and vimentin expression, and inducing autophagy. Mol Med Rep.
12:7603–7608. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Isfort RJ, Cody DB, Lovell G and Doersen
CJ: Analysis of oncogenes, tumor suppressor genes, autocrine
growth-factor production, and differentiation state of human
osteosarcoma cell lines. Mol Carcinog. 14:170–178. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gorgoulis VG, Vassiliou LV, Karakaidos P,
Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr,
Kastrinakis NG, Levy B, et al: Activation of the DNA damage
checkpoint and genomic instability in human precancerous lesions.
Nature. 434:907–913. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mancini L, Paul-Clark MJ, Rosignoli G,
Hannon R, Martin JE, Macintyre I and Perretti M: Calcitonin and
prednisolone display antagonistic actions on bone and have
synergistic effects in experimental arthritis. Am J Pathol.
170:1018–1027. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shih YL, Au MK, Liu KL, Yeh MY, Lee CH,
Lee MH, Lu HF, Yang JL, Wu RS and Chung JG: Ouabain impairs cell
migration, and invasion and alters gene expression of human
osteosarcoma U-2 OS cells. Environ Toxicol. 32:2400–2413. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen HY, Yang MD, Chou YC, Ma YS, Peng SF,
Liao CL, Chen PY, Hsia TC, Lien JC and Chen CH: Ouabain suppresses
cell migration and invasion in human gastric cancer AGS cells
through the inhibition of MMP signaling pathways. Anticancer Res.
41:4365–4375. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma YS, Hsiao YT, Lin JJ, Liao CL, Lin CC
and Chung JG: Phenethyl isothiocyanate (PEITC) and benzyl
isothiocyanate (BITC) inhibit human melanoma A375.S2 cell migration
and invasion by affecting MAPK signaling pathway in vitro.
Anticancer Res. 37:6223–6234. 2017.PubMed/NCBI
|
|
38
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sporn MB: The war on cancer. Lancet.
347:1377–1381. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Roato I, Caldo D, Godio L, D'Amico L,
Giannoni P, Morello E, Quarto R, Molfetta L, Buracco P, Mussa A and
Ferracini R: Bone invading NSCLC cells produce IL-7: Mice model and
human histologic data. BMC Cancer. 10:122010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Santini D, Galluzzo S, Zoccoli A, Pantano
F, Fratto ME, Vincenzi B, Lombardi L, Gucciardino C, Silvestris N,
Riva E, et al: New molecular targets in bone metastases. Cancer
Treat Rev. 36 (Suppl 3):S6–S10. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu Y, Bi T, Shen G, Li Z, Wu G, Wang Z,
Qian L and Gao Q: Lupeol induces apoptosis and inhibits invasion in
gallbladder carcinoma GBC-SD cells by suppression of EGFR/MMP-9
signaling pathway. Cytotechnology. 68:123–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pei H, Yang Y, Cui L, Yang J, Li X, Yang Y
and Duan H: Bisdemethoxycurcumin inhibits ovarian cancer via
reducing oxidative stress mediated MMPs expressions. Sci Rep.
6:287732016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yodkeeree S, Chaiwangyen W, Garbisa S and
Limtrakul P: Curcumin, demethoxycurcumin and bisdemethoxycurcumin
differentially inhibit cancer cell invasion through the
down-regulation of MMPs and uPA. J Nutr Biochem. 20:87–95. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Toth M, Sohail A and Fridman R: Assessment
of gelatinases (MMP-2 and MMP-9) by gelatin zymography. Methods Mol
Biol. 878:121–135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Grzelczyk WL, Szemraj J and
Józefowicz-Korczyńska M: The matrix metalloproteinase in larynx
cancer. Postepy Hig Med Dosw (Online). 70:1190–1197.
2016.PubMed/NCBI
|
|
47
|
Hendrix MJ, Seftor EA, Seftor RE and
Fidler IJ: A simple quantitative assay for studying the invasive
potential of high and low human metastatic variants. Cancer Lett.
38:137–147. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li YH and Zhu C: A modified Boyden chamber
assay for tumor cell transendothelial migration in vitro. Clin Exp
Metastasis. 17:423–429. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Huang T, Kang W, Cheng AS, Yu J and To KF:
The emerging role of Slit-Robo pathway in gastric and other gastro
intestinal cancers. BMC Cancer. 15:9502015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yang M and Huang CZ: Mitogen-activated
protein kinase signaling pathway and invasion and metastasis of
gastric cancer. World J Gastroenterol. 21:11673–11679. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fife CM, McCarroll JA and Kavallaris M:
Movers and shakers: Cell cytoskeleton in cancer metastasis. Br J
Pharmacol. 171:5507–5523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Koul HK, Pal M and Koul S: Role of p38 MAP
kinase signal transduction in solid tumors. Genes Cancer.
4:342–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yu Y, Luk F, Yang JL and Walsh WR:
Ras/Raf/MEK/ERK pathway is associated with lung metastasis of
osteosarcoma in an orthotopic mouse model. Anticancer Res.
31:1147–1152. 2011.PubMed/NCBI
|
|
54
|
Wada T and Penninger JM: Mitogen-activated
protein kinases in apoptosis regulation. Oncogene. 23:2838–2849.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wang C, Zhou X, Li W, Li M, Tu T, Ba X, Wu
Y, Huang Z, Fan G, Zhou G, et al: Macrophage migration inhibitory
factor promotes osteosarcoma growth and lung metastasis through
activating the RAS/MAPK pathway. Cancer Lett. 403:271–279. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Liu Y, Yuan X, Li W, Cao Q and Shu Y:
Aspirin-triggered resolvin D1 inhibits TGF-β1-induced EMT through
the inhibition of the mTOR pathway by reducing the expression of
PKM2 and is closely linked to oxidative stress. Int J Mol Med.
38:1235–1242. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang H, Zhang C, Xu L, Zang K, Ning Z,
Jiang F, Chi H, Zhu X and Meng Z: Bufalin suppresses hepatocellular
carcinoma invasion and metastasis by targeting HIF-1α via the
PI3K/AKT/mTOR pathway. Oncotarget. 7:20193–20208. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Mirzaei S, Saghari S, Bassiri F, Raesi R,
Zarrabi A, Hushmandi K, Sethi G and Tergaonkar V: NF-κB as a
regulator of cancer metastasis and therapy response: A focus on
epithelial-mesenchymal transition. J Cell Physiol. 237:2770–2795.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Pi WS, Cao ZY, Liu JM, Peng AF, Chen WZ,
Chen JW, Huang SH and Liu ZL: Potential molecular mechanisms of
AURKB in the oncogenesis and progression of osteosarcoma cells: A
label-free quantitative proteomics analysis. Technol Cancer Res
Treat. 18:15330338198532622018.PubMed/NCBI
|
|
60
|
Akiyama T and Kawasaki Y: Wnt signalling
and the actin cytoskeleton. Oncogene. 25:7538–7544. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Birkedal-Hansen H, Moore WG, Bodden MK,
Windsor LJ, Birkedal-Hansen B, DeCarlo A and Engler JA: Matrix
metalloproteinases: A review. Crit Rev Oral Biol Med. 4:197–250.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Dutta A, Li J, Lu H, Akech J, Pratap J,
Wang T, Zerlanko BJ, FitzGerald TJ, Jiang Z, Birbe R, et al:
Integrin αvβ6 promotes an osteolytic program in cancer cells by
upregulating MMP2. Cancer Res. 74:1598–1608. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Chu K, Cheng CJ, Ye X, Lee YC, Zurita AJ,
Chen DT, Yu-Lee LY, Zhang S, Yeh ET, Hu MC, et al: Cadherin-11
promotes the metastasis of prostate cancer cells to bone. Mol
Cancer Res. 6:1259–1267. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Chang JW, Kang SU, Shin YS, Seo SJ, Kim
YS, Yang SS, Lee JS, Moon E, Lee K and Kim CH: Combination of NTP
with cetuximab inhibited invasion/migration of cetuximab-resistant
OSCC cells: Involvement of NF-κB signaling. Sci Rep. 5:182082015.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Guarino M, Rubino B and Ballabio G: The
role of epithelial-mesenchymal transition in cancer pathology.
Pathology. 39:305–318. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Yuan Y, Ye HQ and Ren QC: Upregulation of
the BDNF/TrKB pathway promotes epithelial-mesenchymal transition,
as well as the migration and invasion of cervical cancer. Int J
Oncol. 52:461–472. 2018.PubMed/NCBI
|
|
67
|
Cuesta C, Arévalo-Alameda C and Castellano
E: The importance of being PI3K in the RAS signaling network. Genes
(Basel). 12:10942021. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Matsuoka H, Tsubaki M, Yamazoe Y, Ogaki M,
Satou T, Itoh T, Kusunoki T and Nishida S: Tamoxifen inhibits tumor
cell invasion and metastasis in mouse melanoma through suppression
of PKC/MEK/ERK and PKC/PI3K/Akt pathways. Exp Cell Res.
315:2022–2032. 2009. View Article : Google Scholar : PubMed/NCBI
|
